Home / News (Page 3)

News

10th European Life Sciences Forum SachsForum (ELSCEO), ...

Invectys will attend the Sachs Forum in Zürich, 6. March –  7. March 2017   Meet Invectys there ! More information:  invest@invectys.com The 10th…

Read more

Invectys was at J.P. Morgan Conference in San Francisco

J.P. Morgan 35Th Annual Healthcare Conference 2017 San-Francisco…

Read more

Medicen et Invectys: success of the TelVac project

Medicen Paris Region et Invectys annoncent le succès du projet TelVac pour la recherche d’un candidat vaccin contre le cancer…

Read more

Success for the therapeutic vaccine INVAC-1 in cancer

With 7 million raised in the last year and excellent results in terms of tolerance and innocuity, Invectys opens up new hopes in cancer immunotherapy   Paris,…

Read more

Invectys strengthens its intellectual property

Invectys files a patent on the acquisition of antibodies against an immune checkpoint expressed in all types of cancers and strengthens its HLA-G intellectual property…

Read more

Invectys raises 7 million euros more for clinical devel...

With more than 17 million euros raised in total Invectys also benefits from 850,000€ in financing from Bpifrance. Invectys announces fundraising of an additional…

Read more

Invectys starts the third dose level of its phase I ...

Invectys starts the third dose level of its phase I clinical trial evaluating INVAC-1, an innovative anti-cancer therapeutic vaccine  A new clinical hope in cancer…

Read more

Invectys raises 1.7 million Euros more to finance the ...

Invectys raises 1.7 million Euros more to  finance the clinical development of its therapeutic cancer vaccine With a total of 10 million euros raised, new premises,…

Read more